Flavonoids, esophageal/gastric cardia adenocarcinoma and Barretts Esophagus Risk
类黄酮、食管/贲门腺癌和 Barretts 食管风险
基本信息
- 批准号:8243446
- 负责人:
- 金额:$ 7.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-03-01 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdverse effectsAncillary StudyAnthocyanidinAnti-Inflammatory AgentsAnti-inflammatoryApoptosisAspirinBarrett EsophagusBeveragesCase-Control StudiesCell CycleChronicClinicalConnecticutConsumptionCountryCyclin D1DataDatabasesDevelopmentDietDietary intakeEpidemiologic StudiesEsophagealEsophageal AdenocarcinomaEsophagogastric JunctionEsophagusEventFlavanonesFlavonesFlavonoidsFlavonolsFoodFrequenciesGastric AdenocarcinomaGastric Cardia AdenocarcinomaGastroesophageal reflux diseaseGenetic TranscriptionIncidenceIndividualIntakeIsoflavonesLaboratory StudyLengthLinkMalignant NeoplasmsMucous MembraneNew JerseyPTGS2 geneParentsPathologicPharmaceutical PreparationsPlantsQuestionnairesReportingRiskRisk ReductionStagingSubgroupTumor MarkersTumor SubtypeUlcerUnited StatesWashingtonflavan-3-olfruits and vegetablesinhibitor/antagonistinterestoutcome forecastpopulation basedpreventresearch studytumor
项目摘要
DESCRIPTION (provided by applicant): Flavonoids, esophageal/gastric cardia adenocarcinoma and Barrett's esophagus risk ABSTRACT. The incidence of esophageal adenocarcinoma (EA) and gastric cardia adenocarcinoma (GCA) has increased more rapidly than any other cancer in the United States and other Western countries over the past 30-40 years. EA and GCA appear to develop from normal mucosal lining through a sequence of pathologic events. The normal squamous mucosa is believed to be destroyed by chronic gastroesophageal reflux disease (GERD), which can cause ulceration of the esophagus followed by development of Barrett's esophagus (BE). BE is the only known potential precursor of these cancers of the gastroesophageal junction, and the incidence of BE is also increasing. Epidemiologic studies have shown that diets high in fruit and vegetable consumption are inversely associated with EA/GCA and BE. It is hypothesized that flavonoids, which are a group of bioactive polyphenolic compounds that are naturally occurring in fruits, vegetables, and beverages of plant origin, partially account for the risk reduction of fruits and vegetables on these tumors. Experimental studies have supported this hypothesis and have shown that flavonoids regulate cell cycle, proliferation, and apoptosis, which have important chemotherapeutic effects against these tumors. A number of flavonoids are also COX-2 inhibitors and some can suppress COX-2 transcription. Epidemiologic studies have shown a modest reduction in risk of EA/GCA and BE in users of non-steroidal anti-inflammatory drugs (NSAIDS), including aspirin, which are COX-2 inhibitors. However, NSAIDS can have severe side effects so their clinical usage is limited. Therefore, it is of interest to develop a preventin strategy for these tumors that is acceptable for general use. To investigate this potential association between flavonoids and EA/GCA and BE, an ancillary study will be performed to address two specific aims. The first specific aim will determine whether flavonoid consumption is associated with EA/GCA risk from data that was collected as part of a multicenter, population-based case-control study conducted in Connecticut, New Jersey, and western Washington State. The parent study included 293 EA subjects, 261 GCA subjects, and 695 frequency matched control subjects. The second specific aim will determine whether flavonoid consumption is associated with BE risk from data that was collected in a case-control study conducted in western Washington State. The parent study included 193 BE subjects and 211 individually matched control subjects. The two parent case-control studies assessed usual dietary intake using a similar validated food frequency questionnaire (FFQ). For the proposed study, two flavonoid-specific databases will be developed by linking each FFQ on frequency of dietary intake and portion size with existing USDA flavonoid databases. If we are able to demonstrate that total flavonoids or a class of flavonoids are associated with BE or EA/GCA, there is potential to use flavonoids as a risk reduction strategy. This would allow some EA and GCA to be prevented before individuals develop these lethal cancers.
PUBLIC HEALTH RELEVANCE: Esophageal and gastric cardia adenocarcinoma have very poor survival prognoses (normally less than a year), and the only known potential precursor of these cancers is Barrett's esophagus. If we can show an association between flavonoids, which are a naturally occurring compound found in fruits and vegetables, and esophageal adenocarcinoma, gastric cardia adenocarcinoma, or Barrett's esophagus, there is potential to use flavonoids as a risk reduction strategy. This would allow some esophageal or gastric cardia adenocarcinoma to be prevented before individuals develop these deadly cancers.
描述(由申请方提供):食管/贲门腺癌和巴雷特食管风险摘要。在过去的30-40年里,在美国和其他西方国家,食管腺癌(EA)和贲门腺癌(GCA)的发病率比任何其他癌症都增长得更快。EA和GCA似乎是从正常粘膜内层通过一系列病理事件发展而来的。正常鳞状粘膜被认为是由慢性胃食管反流病(GERD),这可能会导致食管溃疡,随后发展为巴雷特食管(BE)的破坏。BE是这些胃食管连接部癌症的唯一已知的潜在前体,并且BE的发病率也在增加。流行病学研究表明,水果和蔬菜消费量高的饮食与EA/GCA和BE呈负相关。据推测,黄酮类化合物是一组天然存在于水果,蔬菜和植物来源的饮料中的生物活性多酚化合物,部分原因是水果和蔬菜对这些肿瘤的风险降低。实验研究支持了这一假设,并表明黄酮类化合物调节细胞周期,增殖和凋亡,对这些肿瘤具有重要的化疗作用。许多类黄酮也是考克斯-2抑制剂,并且一些类黄酮可以抑制考克斯-2转录。流行病学研究表明,使用非甾体抗炎药(NSAIDS)(包括阿司匹林,一种考克斯-2抑制剂)可适度降低EA/GCA和BE的风险。然而,NSAIDS可能具有严重的副作用,因此其临床使用受到限制。因此,开发一种可被普遍接受的针对这些肿瘤的预防策略是有意义的。为了研究黄酮类化合物与EA/GCA和BE之间的这种潜在关联,将进行辅助研究以解决两个特定目标。第一个具体目标将确定类黄酮消费是否与EA/GCA风险相关,这些数据是作为在康涅狄格州,新泽西和西部华盛顿州进行的多中心,基于人群的病例对照研究的一部分收集的。母研究包括293名EA受试者,261名GCA受试者和695名频率匹配的对照受试者。第二个具体目标将确定类黄酮的消费是否与BE风险的数据,收集在西部华盛顿州进行的病例对照研究。母研究包括193例BE受试者和211例个体匹配的对照受试者。两项母病例对照研究使用类似的经验证的食物频率问卷(FFQ)评估了日常饮食摄入量。对于拟议的研究,将通过将每个关于饮食摄入频率和份量的FFQ与现有的USDA类黄酮数据库联系起来,开发两个类黄酮特异性数据库。如果我们能够证明总黄酮或一类黄酮类化合物与BE或EA/GCA相关,则有可能使用黄酮类化合物作为风险降低策略。这将使一些EA和GCA在个体发展这些致命癌症之前得到预防。
公共卫生相关性:食管和贲门腺癌的生存期非常短(通常不到一年),这些癌症唯一已知的潜在前体是巴雷特食管。如果我们能证明类黄酮(一种在水果和蔬菜中发现的天然化合物)与食管腺癌、贲门腺癌或巴雷特食管之间的关联,就有可能使用类黄酮作为降低风险的策略。这将使一些食管或贲门腺癌,以防止个人发展这些致命的癌症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARILIE D. GAMMON其他文献
MARILIE D. GAMMON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARILIE D. GAMMON', 18)}}的其他基金
Flavonoids, esophageal/gastric cardia adenocarcinoma and Barretts Esophagus Risk
类黄酮、食管/贲门腺癌和 Barretts 食管风险
- 批准号:
8434846 - 财政年份:2012
- 资助金额:
$ 7.22万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 7.22万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 7.22万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 7.22万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 7.22万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 7.22万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 7.22万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 7.22万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 7.22万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 7.22万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 7.22万 - 项目类别:
Research Grant